SCHEMBL7684289

SCHEMBL7684289

CC(C)(C)OC(=O)[C@@H]1CCCC[C@H]1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
EPHX1 P07099 3/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
HPGD P15428 1/20 0.33
SLC6A2 P23975 1/20 0.33
BTK Q06187 1/20 0.33
PDE4B Q07343 1/20 0.33
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
NPY1R P25929 1/20 0.31
NPY2R P49146 1/20 0.31
NPY4R P50391 1/20 0.31
NPY5R Q15761 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7684286 1.00 CA1 (0.38) CA1CA2CA4CHRM2CHRM1
SCHEMBL7684293 1.00 CA1 (0.38) CA1CA2CA4CHRM2CHRM1
SCHEMBL1296115 0.87 EPHX1 (0.41) CHRM2CHRM1CHRM3EPHX1GAA
SCHEMBL26460992 0.82 EPHX1 (0.52) CA1CA2CA4CHRM2CHRM1
SCHEMBL1296980 0.80 BTK (0.44) EPHX1GAABTK
SCHEMBL1296390 0.80 SLC6A2 (0.46) CHRM2CHRM3EPHX1GAASLC6A2
SCHEMBL27551188 0.78 EPHX1 (0.39) CHRM2CHRM1CHRM3EPHX1GAA
SCHEMBL20929031 0.78 EPHX1 (0.37) CHRM2CHRM1CHRM3EPHX1GAA
SCHEMBL26461763 0.78 MAPK1 (0.37) CHRM2CHRM1CHRM3EPHX1GAA
SCHEMBL1297808 0.78 BTK (0.38) CHRM2CHRM1CHRM3EPHX1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372733-B1 HEXAHYDRO-5-IMINO-3-ALKYL OR ISOALKYL-1,4-THIAZEPINE HYDROCHLORIDE OR ACETIC ACID SALTS; USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS, GASTROINTESTINAL DISORDERS AND INFLAMMATION MERCK & CO., INC. 2002-04-16 US disclosed